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Antigen (Ag)-specific immunity is orchestrated 
by T cells that determine the specificity of 
immune responses via their clonally distributed 
 TCRs. A wide array of Ags is presented to 
TCRs, and to counteract this diversity, the host 
possesses a vast T cell repertoire. TCR diver-
sity is generated via gene rearrangement within 
the variable (V) domains of the TCR; namely, 
the V and junction (J) gene segments define the 
V chain, whereas the V chain is composed 
of rearranged V, D (diversity), and J gene seg-
ments, in addition to non–nucleotide-encoded 
diversity (N) at these gene segment boundaries. 
This diversity is manifested in the complemen-
tarity determining regions (CDR) of the TCR, 
providing key sites that interact with the Ag-
presenting molecule (Clements et al., 2006). 
Despite this TCR diversity and its importance 
in immunity, there are numerous examples of 
TCR bias in protective immunity and auto-
immunity in which restricted V gene usage 
and/or sequence conservation within CDR3 
loops defines the immune response to specific 
Ags (Turner et al., 2006; Godfrey et al., 2008; 
Gras et al., 2008). Why this should occur, and 
the factors that shape biased TCR usage, re-
main unclear.
TCRs recognize peptides complexed to 
the MHC (pMHC), and the insight gleaned 
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Mucosal-associated invariant T (MAIT) cells express a semiinvariant  T cell receptor 
(TCR) that binds MHC class I–like molecule (MR1). However, the molecular basis for MAIT 
TCR recognition by MR1 is unknown. In this study, we present the crystal structure of a 
human V7.2J33-V2 MAIT TCR. Mutagenesis revealed highly conserved requirements 
for the MAIT TCR–MR1 interaction across different human MAIT TCRs stimulated by 
distinct microbial sources. Individual residues within the MAIT TCR  chain were dispens-
able for the interaction with MR1, whereas the invariant MAIT TCR  chain controlled 
specificity through a small number of residues, which are conserved across species and 
located within the V-J regions. Mutagenesis of MR1 showed that only two residues, 
which were centrally positioned and on opposing sides of the antigen-binding cleft of 
MR1, were essential for MAIT cell activation. The mutagenesis data are consistent with a 
centrally located MAIT TCR–MR1 docking that was dominated by the  chain of the MAIT 
TCR. This candidate docking mode contrasts with that of the NKT TCR–CD1d-antigen 
interaction, in which both the  and  chain of the NKT TCR is required for ligation above 
the F-pocket of CD1d.
© 2012 Reantragoon et al. This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first 
six months after the publication date (see http://www.rupress.org/terms). 
After six months it is available under a Creative Commons License (Attribution–
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detected in human blood, the gastrointestinal mucosa, and 
mesenteric lymph nodes. Furthermore, MAIT cells, like NKT 
cells, rapidly produce a broad range of cytokines upon activa-
tion (Kawachi et al., 2006; Martin et al., 2009). There are 
further parallels between MR1-restricted MAIT cells and 
CD1d-restricted NKT cells in that, like NKT cells, MAIT 
cells express a semiinvariant TCR comprised of an invari-
ant TCR  chain (V19J33 in mice, or the homologous 
V7.2J33 in humans) in combination with TCR-V6 or 
V8 in mice, TCR-V2 or V13 in humans (Tilloy et al., 
1999). The semiinvariant and evolutionarily conserved nature 
of the MAIT TCR suggests that MAIT cells may potentially 
be specific for an important, albeit limited and atypical, class 
of Ags presented by the MR1 molecule. Nevertheless, 
despite the limited TCR repertoire of MAIT cells, they respond 
to a surprisingly broad range of microorganisms, including 
diverse strains of bacteria and yeast, suggesting the existence 
of a conserved Ag (or family of Ags), which is common to 
these cellular organisms, presented to MAIT cells in an MR1-
dependent manner (Gold et al., 2010; Le Bourhis et al., 2010). 
Indeed, endogenous cell surface expression levels of MR1 
are very low, suggesting that a bacterial Ag is required to 
stabilize MR1 and/or increase its MR1 presentation (Chua 
et al., 2011). Alternatively, it is possible that bacterial infec-
tion may indirectly result in MAIT cell activation through 
activation of Toll-like receptors or other innate pathways, as 
occurs for NKT cells (Brigl et al., 2011). However, this seems 
unlikely for MAIT cells, as previous studies indicate that 
their activation can occur independently of My88D, TRIF, 
Nod1,-2, N1rp3, Asc, Ips TLR2, and TLR4 (Gold et al., 
2010; Le Bourhis et al., 2010). Furthermore, MAIT cells can 
be activated by fixed APCs cultured in the presence of bacte-
ria in an MR1-dependent manner (Le Bourhis et al., 2010). 
Hence, it is a simpler proposition that MAIT cell activation 
results from TCR recognition of MR1 complexed with a 
bacterial Ag, although the nature of a candidate bacterial Ag 
has yet to be identified.
Because MAIT cells are largely defined by their unique, 
semiinvariant TCR, their Ag-restricting element (MR1), 
and, potentially, an unusual Ag specificity (Huang et al., 2008, 
2009), a critical step in understanding the biology of these 
cells will be to understand their TCR-specificity.
RESULTS
MAIT TCR structure
In humans, the MAIT TCR comprises the TRAV1-2  chain 
(V7.2-J33) and is generally assembled with either the TRBV6 
(V13) or TRBV20 (V2)  chains, with the CDR3 loop 
being hypervariable (Tilloy et al., 1999). In mouse MAIT cells, 
V19-J33 assembles with either TRBV-19 (V6) or TRBV13 
(V8). We expanded and cloned MAIT cells from the PBMCs 
of a healthy donor and isolated the TCR  and  chain cDNAs 
for further investigation. Three clones were selected, each 
expressing the V7.2-J33 assembled with either a V13.3 
(clone BV6-1), V13.5 (clone BV6-4), or V2  chain (clone 
BV20). TRBV6-1 (V13.3) and TRBV20 (V2) sequences 
from structures of TCR–pMHC complexes has been ex-
tremely informative in understanding how the TCR simulta-
neously, and specifically, focuses with host MHC and fragments 
of foreign peptide Ag (Rudolph et al., 2006; Marrack et al., 
2008; Burrows et al., 2010). However, there are other Ag-
presenting molecules of the immune system that the TCR 
specifically interacts with. For example, the CD1 family pres-
ents lipid-based Ags to T cells (Godfrey et al., 2008). The 
most extensively studied group of T cells that interact with 
lipid-based Ags are the natural killer T (NKT) cells, which 
express an NKT TCR that specifically recognizes CD1d-Ag 
in mice and humans (Bendelac et al., 2007; Godfrey et al., 
2010a). Similar to some MHC-restricted responses, NKT 
cells use a limited range of TCR genes, such that human 
NKT cells typically express an invariant V24-J18 rear-
ranged TCR  chain and most express a V11 TCR  chain 
(Godfrey et al., 2010a). The most widely studied glyco-
lipid Ag for activating NKT cells is a synthetic -glycolipid, 
-galactosylceramide. The structures of human and mouse 
NKT TCRs in complex with CD1d--galactosylceramide 
and other lipid Ags have recently been determined (Godfrey 
and Rossjohn, 2011). These NKT TCR–CD1d-Ag com-
plexes demonstrate a conserved docking strategy that differs 
from all known TCR-pMHC interactions, whereupon the 
NKT TCR adopted a tilted and parallel docking mode in re-
lation to the CD1d Ag-binding cleft (Godfrey et al., 2008). 
The invariant NKT TCR  chain dominated this inter-
action, with the CDR1 loop predominantly interacting with 
the lipid Ag, whereas the CDR3 loop played a central role, 
contacting CD1d and the lipid Ag. The roles of the human 
V11 and the homologous mouse V8.2 chain were essen-
tially restricted to the CDR2 loop that interacted with 
CD1d (Godfrey et al., 2010a; Joyce et al., 2011). Neverthe-
less, the CDR3 loop can play an important role in deter-
mining CD1d autoreactivity (Matulis et al., 2010; Mallevaey 
et al., 2011). Thus, the structural studies have been very infor-
mative in understanding how a TCR can recognize a lipid-laden 
Ag-presenting molecule, but it remains unclear how TCRs can 
interact with other specialized Ag-presenting molecules of 
the immune system.
Mucosal-associated invariant T (MAIT) cells are a sub-
population of T cells that are restricted by the monomorphic 
MHC class 1–like molecule (MR1; Treiner et al., 2003; 
Gapin, 2009; Le Bourhis et al., 2011). The role of MAIT 
cells in immunity is emerging and is supported by their con-
servation across species such as humans, cattle, and mice, as 
well as recent data implying protective function in autoim-
munity and certain infections (Gold et al., 2010; Le Bourhis 
et al., 2010; Le Bourhis et al., 2011; Miyazaki et al., 2011; 
Chiba et al., 2012). In some regards, MAIT cells are reminis-
cent of CD1d-restricted NKT cells, although in humans, 
MAIT cells are much more abundant, comprising 1–10% of 
peripheral blood T cells when compared with their NKT cell 
counterparts (typically <0.1%), and MAIT cells can consti-
tute up to 50% of liver T cells (Godfrey et al., 2010b; 
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the V2 MAIT TCR (Fig. 1 B). All six CDR loops were 
well-ordered in the electron density, suggesting little mobil-
ity of these CDR loops, in contrast to the flexibility of the 
CDR loops typical of several MHC-restricted TCRs (Garcia 
et al., 1998; Reiser et al., 2002; Godfrey et al., 2008), imply-
ing that the MAIT TCR possesses a rigid, preformed MR1-
binding interface.
Unless explicitly stated, comparative structural analyses 
have been restricted to the semiinvariant human V24-V11 
NKT TCR (NKT15; Kjer-Nielsen et al., 2006; Fig. 1 C). 
The root mean square deviation for the pairwise superposition 
between the V2 MAIT TCR and the V11 NKT TCR 
was 0.90 Å (347 residues), highlighting that these semiin-
variant TCRs adopt very similar topologies. Although the 
constant domains of the V2 MAIT and V11 NKT TCR 
superpose closely with each other (root mean square devia-
tion [rmsd], 0.33 Å; 160 residues), differences in juxtaposition 
between the V and V domains were observed, reflecting 
differences in the interchain pairing of the NKT TCR and the 
MAIT TCR. Moreover, comparative analyses revealed struc-
tural divergences within the respective V and V domains. 
For example, pairwise superposition between MAIT and NKT 
V domains was 0.45 Å (75 residues), whereas the pairwise 
superposition between the V domains was 0.70 Å (75 residues), 
showing that the V domain was more divergent than the 
V domain, as expected from the markedly differing nature 
of the V chains. Further, although the CDR1 loop adopts 
a similar conformation to the corresponding loop in the NKT 
TCR (Kjer-Nielsen et al., 2006), the remaining CDR loop 
conformations are markedly different, presumably reflect-
ing the fact that the MAIT and NKT TCRs engage MR1 
and CD1d, respectively (Fig. 1 and Fig. 2).
The MAIT TCR V-V interface uses both the V7.2 
and J33 gene segment of the invariant chain. The sequences 
encoded by the invariant J and hypervariable D-N-J 
region create the CDR3 loops that are centrally located at 
the Ag-binding interface (Fig. 1 B). Namely, the residues 
lining this region are mostly apolar in nature, in stark con-
trast to the electropositive surface of NKT TCR (Fig. 2 A). 
The central binding pocket of the MAIT TCR is com-
prised of Met91 and Arg97, which is flanked by Tyr95 
from the CDR3 loop and Phe102 from the CDR3 
loop, the latter of which packs against framework residue 
Tyr48 from the CDR2 loop (Fig. 2 B). The tips of the 
CDR1, CDR2, and CDR3 loops are polar (Ser27, 
Asn30, Asp52, Asp92, and Asn94), if not featureless 
(Fig. 2 C). The residues from the germline-encoded regions 
of the V chain are mostly flat and featureless, with Glu52 
from the CDR2 loop, and Phe28 from the CDR1 loop 
representing prominent side chains, nevertheless Phe28 lies 
parallel with, and away from the Ag-binding interface (Fig. 2 D). 
Thus, in marked contrast to that of the NKT TCR, which 
possesses a large number of charged residues within the CDR3 
loop, the J18-encoded CDR3 loop, and two tyrosine 
residues encoded within the CDR2 loop (Fig. 2, E and F), 
a defining feature of the MAIT TCR is the cluster of 
were derived from published sequence data (Tilloy et al., 
1999). The TRBV6-4 (V13.5) sequence was derived from 
FACS single-cell sorting and RT-PCR analysis. A sequence 
alignment of the CDR loops of the three MAIT TCRs is shown 
(Fig. S1 and Fig. S2).
To begin to understand MAIT TCR function, the extra-
cellular domains of the two V13 and single V2 MAIT 
TCRs were expressed in Escherichia coli, refolded into a native 
conformation, and purified. The functional integrity of the 
refolded TCRs was assessed by gel filtration chromatography 
and ELISA reactivity with the TCR-specific conformation-
dependent mAb 12H8 (unpublished data). Although the two 
V13 MAIT TCRs failed to crystallize (not depicted), the 
V2 MAIT TCR crystallized, and its structure was subse-
quently determined to 1.7 Å resolution (Table 1). Given the 
resolution, the quality of the electron density for the V2 
MAIT TCR, and in particular the Ag-binding site, was ex-
cellent (Fig. 1 A).
The overall structure of the MAIT V2 TCR resembles 
that of other MHC- and CD1d-restricted  TCRs, namely 
it comprises four immunoglobulin-like domains with a con-
stant (C) and variable (V) domain in each chain, with their 
respective domains packing against each other (Fig. 1 B; 
Kjer-Nielsen et al., 2002; Rudolph et al., 2006). The V do-
main of each chain is composed of three CDRs and together 
these six hypervariable loops form a ligand-binding site for 
Table 1. Data collection and refinement statistics
MAIT TCR
Data collection
Temperature (K) 100 
Resolution limits (Å) 50-1.7 (1.79-1.70)
Space group P212121
Cell dimensions (Å) a = 41.96; b = 64.51; c = 155.12; 
 =  =  = 90.00°
Total no. observations 351,526
No. unique observations 45,957
Multiplicitya 7.6 (7.4)
Data completenessa 97.1 (92.6)
I/1a 13.7 (2.5)




Nonhydrogen atoms: protein/ water 3,472/271
Ramachandran plot: most favored/
allowed region (%)
89.1/10.9
B-factors: average main chain/
average side chain/water (Å2)
17.3/20.4/26.7
rmsd bonds (Å) 0.014
rmsd angles (°) 1.500
aValues in parentheses refer to the highest resolution bin.
bRp.i.m = hkl [1/(N  1)]1/2 i | Ihkl, i <Ihkl> | / hkl <Ihkl>
cRfactor = ( | |Fo| |Fc| |) / ( |Fo|), for all data except as indicated in footnote d.
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MAIT TCR recognition is more de-
pendent on the invariant encoded  chain, 
with a less obvious contribution from 
the V residues.
MAIT–MR1 recognition
It is thought that MAIT cells may be able 
to potentially recognize unknown micro-
bial Ags presented by MR1 (Gold et al., 
2010; Le Bourhis et al., 2010), although 
definitive identification of a bacterially en-
coded Ag is lacking at present. To explore 
the activation of human MAIT TCRs by 
MR1, we transduced genes for MAIT 
TCRs using TRBV20 (V2), TRBV6-1 
(V13.3), or TRBV6-4 (V13.5)  chains 
into either of the two human leukemia 
T cell lines SKW3 (Hundhausen et al., 
1992; Gras et al., 2010) and Jurkat (Gillis 
and Watson, 1980), thus creating clonal 
cellular reagents for T cell recognition 
(SKW3.TRBV20, SKW3.TRBV6-1, and 
SKW3.TRBV6-4; Jurkat.BV20, Jurkat.
BV6-1, and Jurkat.BV6-4). To generate 
Ag-presenting cells, HeLa cells and the 
MHC-I–deficient human lymphoblastoid 
cell line C1R were transduced with the gene for human 
MR1. C1R cells express low levels of endogenous MR1, and 
thus were also used as untransduced APCs (Fig. 3 A). T cell 
activation was assayed by CD69 up-regulation that was deter-
mined by flow cytometry. Mindful that MAIT cells can be 
activated by various strains of bacteria (Gold et al., 2010; 
Le Bourhis et al., 2011), we first determined that SKW3 T cells 
transduced with MAIT TCRs were activated by Ag-presenting 
cells infected with Salmonella enterica serovar Typhimurium. 
SKW3.TRBV20 MAIT cells were activated by C1R cells 
(expressing endogenous MR1) only when infected with 
S. typhimurium, and this activation was blocked by addition of 
the MR1-specific mAb 26.5 (Huang et al., 2005) but not by 
the MHC-I-specific mAb W6/32 (Parham et al., 1979; Fig. 3 B). 
Similar results were obtained when SKW3.TRBV6-1 and 
SKW3.TRBV6-4 cells were used as responder cells (unpub-
lished data). Similarly, HeLa cells transduced with MR1 could 
activate Jurkat.BV6-1 cells (Fig. 3 C), as well as Jurkat.BV20 
aromatic residues within the central region of its combin-
ing site (Fig. 2 B).
The MAIT TCR V chain is highly conserved across 
species (Tilloy et al., 1999), with the surface exposed resi-
dues from the CDR1 loop (Ser27, Gly28, and Asn30), 
the CDR2 loop (Tyr48, Val50, Leu51, Asp52, and 
Gly53), and the CDR3 loop (Asp92, Asn94, Tyr95, 
and Ile98) conserved across four species (Goldfinch et al., 
2010). However, there is less conservation in the germline-
encoded CDR loops of the V2 and V13 chains, with a 
conserved Asn-His-Asp motif present in the CDR1 loop 
of mouse V6 and V8.1 (Fig. S2). However, human V2 
and V13 do not contain this motif, and there is little con-
servation of CDR2 loops across, or within, human and 
mouse sequences apart from a Tyr/Thr-Ser motif at the 
junction of this loop (Fig. S2). Accordingly, the structural 
data suggests that although the MAIT TCR resembles the 
overall architecture of MHC- and CD1d-restricted TCRs, 
Figure 1. Structures of MAIT and NKT TCRs. 
(A) 2Fo-Fc electron density map shown as a blue 
mesh and contoured at 1 sigma for the CDR3 
and CDR3 of the MAIT TCR. (B) Structure of 
MAIT TCR and amino acid composition of CDR3 
loops. TCR chain, cyan; TCR chain, light green; 
CDR1, purple; CDR2, dark green; CDR1, teal, 
CDR2, ruby; CDR3 loops, color coded according 
to their genetic origin (right). (C) Structure of NKT 
TCR and amino acid composition of CDR3 loops. 
TCR chain, salmon; TCR chain, gray; CDR loops, 
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Gly100, and Phe102). Leu26Ala 
was remote from the likely MAIT 
TCR–MR1-Ag–binding site and was 
selected as a negative control, whereas 
all the other mutants were at surface 
exposed positions within the CDR 
loops. As these residues were surface 
exposed, they were unlikely to affect 
the conformation of the CDR loop 
per se, and thus their mutation was 
predicted to not indirectly impact on 
MR1-induced activation. Thus, any 
effect observed by these alanine mutations could be attrib-
utable to impacting directly on MR1 binding.
Constructs containing MAIT TCR alanine mutations 
were transduced into SKW3 and Jurkat cells, and the cell 
surface expression of MAIT TCR was closely matched as 
determined by flow cytometry using staining for cell sur-
face CD3 expression and coexpression of GFP (unpublished 
data). We then tested the impact of these mutants using 
C1R APCs infected with S. typhimurium (Fig. 4). We ob-
served that mutations at six residues markedly impaired re-
sponses (Gly28, Asn30, Tyr48, Asp92, Asn94, and 
Tyr95; Fig. 4 A). Surprisingly, none of the  chain mutants 
showed decreased activation responses to S. typhimurium, 
suggesting that no individual residue within the  chain was 
essential for the MAIT TCR–MR1 recognition (Fig. 4 B). 
All 25 of the mutant SKW3 cells expressing TRBV20 Ala-
substitutions were activated by beads coated with anti-CD3 and 
anti-CD28 mAbs indicating intact signaling capacity was re-
tained by the mutant TCRs (unpublished data). Similar results 
and Jurkat.BV6-4 cells (not depicted). Activation of MAIT 
TCR–transduced SKW3 and Jurkat cells was dependent on 
the multiplicity of infection (MOI) of S. typhimurium infec-
tion, and this activation was blocked by the MR1-specific 
mAb 26.5. Thus, both the SKW3 and Jurkat cell lines trans-
duced with MAIT TCRs were activated in an MR1-re-
stricted manner.
Specificity determinants of the MAIT-MR1 interaction
To further probe the underlying basis of the MR1-induced 
MAIT TCR activation, we generated a panel of MAIT 
TCR mutants based on the nonliganded V2 (TRBV20) 
MAIT TCR structure. In total, 25 single-site alanine-
scanning mutations were made in the TRBV20 MAIT 
TCR, 11 in the V chain (CDR1: Ser27, Gly28, and 
Asn30; CDR2: Tyr48, Val50, Leu51, and Asp52; CDR3: 
Asp92, Ser93, Asn94, Tyr95), and 14 in the V chain (CDR1: 
Leu26, Phe28, Gln29, Thr31, and Thr32; CDR2: Asn51, 
Glu52, Gly53, Ser54, and Lys55; CDR3: Arg97, Ser99, 
Figure 2. Electrostatic surface and 
close-up view of CDR loops. (A) Electro-
static calculations were performed using the 
MAIT TCR and NKT TCR (Protein Data Bank 
accession code 2EYS). Coordinate preparation 
was performed using the PDB2PQR server 
(v1.7; Dolinsky et al., 2007). Electrostatic cal-
culations were subsequently performed using 
the APBS plug-in in PyMOL (DeLano, 2002; 
v1.1.0 and v1.2.x, respectively) with 0.15 M 
concentration for the +1 and 1 ion species. 
(B) Central binding pocket of the MAIT TCR. 
CDR2, dark green; CDR3, yellow; CDR3, 
orange. (C) Residues at the tip of CDR loops 
of MAIT TCR. CDR1, purple; CDR2 and 
CDR3, color coded as in B. (D) CDR1 (teal) 
and CDR2 (ruby) loops of the MAIT TCR. 
(E) Central binding pocket of the NKT TCR. 
CDR loops, color coded as in B. (F) Tyrosines 
of the CDR2 loop (ruby) of the NKT TCR.  
(G) Energetically important residues at the bind-
ing interface of the MAIT TCR. TCR  chain, 
cyan; TCR chain, light green; CDR1, purple; 
CDR2, dark green; CDR3, yellow; CDR1, 
teal, CDR2, ruby; CDR3, orange. Energetically 
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of the MAIT clone 




and the drug aba-
cavir and expresses 
a TRBV20  chain similar to the  chain of MAIT clone 
TRBV20. The CDR3 loop of MAIT clone 6–1 was re-
placed with the SB27 CDR3 loop, whereas the CDR3 
loop of MAIT clone TRBV20 was replaced with the CDR3 
loop of clone ABC, and these hybrid TCRs were ex-
pressed with V7.2J33 in SKW3 T cells (Fig. S3). When 
stimulated by C1R cells infected with S. typhimurium, neither 
the SKW3 cells expressing MAIT.TRBV6-1/SB27.CDR3 
nor the cells expressing MAIT.TRBV20/ABC.CDR3 
were activated (Fig. 4 D). Activation by anti-CD3 and 
anti-CD28 beads was identical in all transduced T cells 
(unpublished data), and the parental wild-type MAIT cells were 
activated normally by S. typhimurium–infected C1R cells. Ac-
cordingly, although single-residue mutants in the CDR3  
of the MAIT-TRBV20 TCR had no impact on MAIT TCR 
activation, swapping the full CDR3 loop of both this 
MAIT-TRBV20 TCR and the MAIT-TRBV6-1 TCR com-
pletely abolished MAIT TCR activation in both of these 
clones. This indicates that redundancy in the important 
contacts from this loop or that the conformation of the 
CDR3 loop can impact on the MAIT TCR–MR1 inter-
action, possibly via steric hindrance mechanisms.
Identical TCR specificity pattern independent  
of bacterial stimulators
We next examined whether the specificity pattern observed 
in the TRBV20 SKW3 mutants stimulated by S. typhimurium 
was the same or different when the cells were stimulated by 
were obtained using transduced Jurkat cells as T cells re-
sponders and we observed the Jurkat cells were slightly less 
sensitive than the transduced SKW3 cells (unpublished 
data). Thus, the mutational data suggest a limited number of 
V residues of the MAIT TCR are critical for the MR1-
induced activation.
Role of the V interactions in MAIT specificity
To further examine the role of V residues in MAIT TCR 
activation we examined the impact of alanine mutations in 
five solvent exposed CDR1 residues (Asn28, His29, Asn30, 
Ser31, and Tyr33; as well as a control residue, Asn66, of the 
MAIT TRBV6-1 TCR. The structure of the SB27 TCR 
(Tynan et al., 2005b) was used to determine solvent ex-
posed residues in the CDR1 loop of the TRBV6-1  chain 
from the MAIT TRBV6-1 TCR. Constructs containing 
these alanine mutations were transduced into SKW3 cells 
that were matched for TCR expression as described above. 
Testing the impact of these mutants using wild-type C1R 
APCs infected with S. typhimurium revealed that none of 
the mutants individually had an adverse impact on MR1-
restricted activation by the mutated MAIT TCRs (Fig. 4 C). 
These findings underscore the observation that no indi-
vidual germline-encoded residue within the V chain is 
essential in mediating MR1-restricted activation of the 
MAIT TCR.
Next, given that none of the individual CDR3 muta-
tions in TRBV20 had any apparent impact on MAIT cell acti-
vation, we created T cells expressing TCRs where the whole 
CDR3 of a MAIT TCR was swapped for that of another with 
non–MAIT TCR specificity. For this purpose, we selected two 
unrelated T cell clones with V usage similar to MAIT clone 
TRBV6-1 and clone TRBV20. The first, SB27, recognizes 
HLA-B*3501 complexed to a peptide from an Epstein–Barr 
virus Ag and uses a TRBV6-1  chain similar to the  chain 
Figure 3. Characterization of APC lines 
and MAIT TCR-transduced T cell lines. 
(A) Staining of HeLa and C1R cells with the 
MR1-reactive mAb 26.5 by indirect immuno-
fluorescence. FACS histograms compare in-
tensity of staining with either an isotype 
control antibody 8A5 (+ Isotype), or with anti-
MR1 antibody (+26.5). HeLa and C1R cells 
transduced with MR1 were also stained with 
26.5 (h.MR1 + 26.5). (B) SKW3.TRBV20 cells 
were incubated with C1R cells infected with 
Salmonella typhimurium, either in the ab-
sence (No Ab) or presence of either an  
MR1-reactive mAb (+ 26.5) or the HLA class I– 
reactive mAb W6/32 (+ Isotype). SKW3.
TRBV20 cells were subsequently stained for 
CD69 cell surface expression (mean fluores-
cence intensity [MFI] values shown) and ana-
lyzed by flow cytometry. (C) Jurkat.TRBV6-1 
cells were incubated with MR1-transduced 
HeLa cells infected with S. typhimurium,  
either in the absence (No Ab) or presence of 
either an MR1-reactive mAb (+ 26.5) or the 
HLA class I–reactive mAb W6/32 (+ Isotype). 
Jurkat.TRBV6-1 cells were subsequently 
stained for CD69 cell surface expression (MFI 
values shown) and analyzed by flow cytom-
etry. Experiments in A–C were performed 
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Conserved fine specificity by other MAIT TCRs
We next examined whether the same pattern of MAIT TCR 
specificity was evident when the mutated TRAV1-2  chains 
(V7.2-J33; selected  chain mutants: Ser27, Gly28, Asn30, 
Tyr48, Asp92, Ser93, Asn94, and Tyr95) were paired with other 
MAIT V families (Tilloy et al., 1999). Thus, we transduced 
SKW3 T cells with genes encoding the mutant TRAV1-2 
(V7.2/J33) TCR  chain and either the TRBV6-1 or the 
TRBV6-4  chains, representing the alternate V13 family 
preferentially used by some human MAIT cells. The trans-
duced cells were stimulated by C1R APCs infected with 
S. typhimurium, K. pneumoniae, P. aeruginosa, or S. epidermidis, 
and activation of SKW3 cells was determined by staining and 
flow cytometric analysis of surface CD69 expression (Fig. 6, 
A and B). Except for activation responses in SKW3.TRBV6-4 
cells with the Asn94Ala mutation being only minimally im-
paired, the fine specificity pattern of reactivity of the TCR  
other bacteria. C1R APCs were independently infected with 
either the Gram-negative bacteria Escherichia coli, Klebsiella 
pneumoniae, and Pseudomonas aeruginosa or with the Gram-
positive bacterium Staphylococcus epidermidis, and the infected 
APCs were used to stimulate the SKW3.TRBV20 mutant 
T cells (Fig. 5). The pattern of T cell activation was indistin-
guishable from that observed when the mutants were stimu-
lated by C1R infected with S. typhimurium, such that V 
residues Gly28, Asn30, Tyr48, Asp92, Asn94, and Tyr95 
markedly reduced MAIT TCR activation. Again, there was no 
consistent influence of TCR  chain mutations on T cell ac-
tivation by any of the bacteria, with the exception of assay 
variation in T cell responses of some of the V mutants (e.g., 
S. epidermidis, Gly100Ala, and Phe102Ala). These results 
suggest that the MAIT TCR acts like a pattern recognition 
receptor, with a conserved MR1-binding mode, irrespective 
of the source of bacterial stimulation.
Figure 4. Activation of mutant SKW3.BV20 cells by S. typhimurium. 11 mutant  chain (A) and 14 mutant  chain (B) SKW3.TRBV20 cell lines 
were incubated with C1R cells infected with S. typhimurium at a MOI of 100. Shaded bars show the fold increase in CD69 surface expression (fold in-
crease in MFI) of mutant SKW3.TRBV20 cells co-incubated with C1R cells infected with S. typhimurium compared with SKW3.BV20 cells co-incubated 
with uninfected C1R cells (open bars). A positive control, wild-type SKW3.TRBV20 (TRBV20.WT), and a negative control, SKW3.LC13 (LC13.WT), were in-
cluded. The mutant CDR1 Leu26A cell line was included as an internal control where activation was expected to remain intact. (C) MAIT.TRBV6-1 TCRs 
with six separate solvent-exposed residues of the  chain mutated to alanine were transduced into SKW3 cells and tested in the same manner as the 
mutant SKW3.TRBV20 cell lines in A and B. (D) SKW3 cells transduced with MAIT TCRs containing CDR3 regions of the MAIT.TRBV6-1 TCR or the MAIT.
TRBV20 TCR exchanged with the CDR3 regions of known functional TCRs using TRBV6-1 or TRBV20, respectively, were then tested in the same manner 
as the mutant SKW3.TRBV20 cell lines in A and B. The following SKW3-transduced cell lines were tested: wild-type SKW3.TRBV6-1 cells (TRBV6-1.WT); 
SKW3.TRBV6-1 cells with a TCR containing the SB27 TRBV6-1 CDR3 region (TRBV6-1/SB27); wild-type SKW3.TRBV20 cells (TRBV20.WT); SKW3.TRBV20 
cells with a TCR containing the ABC TRBV20 CDR3 region (TRBV20/ABC; to be described elsewhere); SKW3 cells with a TCR containing the MAIT invari-
ant  chain paired with the LC13 TCR  chain (MAIT.LC13); and SKW3 cells with the wild-type LC13 TCR (LC13.WT). The experiments shown in A–D 
were also performed at an MOI of 1 and 10 and yielded similar results (not depicted). The experiments shown in A and B and C and D were done three 
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length and breadth of the Ag-binding cleft of MR1. Accord-
ingly, the MR1 mutagenesis approach enabled us to gain a 
broad perspective on the chemistry of the interaction, as well 
as the energetic requirement of the MR1 residues that are 
central to the interaction with the MAIT TCR. The 14 single-
site alanine mutants were transfected into C1R cells, and cells 
were then sorted for high levels of MR1 expression by flow 
cytometry using coexpressed GFP (Fig. 7).
Jurkat cells expressing human MAIT TCRs (with either 
TRBV6-1, TRBV6-4, or TRBV20 pairing  chains) were 
incubated for 16–20 h, with C1R cells expressing either 
wild-type or each mutant MR1, in the absence or presence 
of S. typhimurium. Activation of MAIT TCR–expressing 
Jurkat cells was determined by flow cytometric analysis of 
up-regulation of cell surface CD69 expression. Of the 14 MR1 
mutants tested, mutation of 9 residues (Asp57, Arg61, Met72, 
Val75, Arg79, Thr138, Gln141, Asn155, and Arg167) had no 
significant impact on MAIT activation; two residues (Asn146 
and His148) had a minor effect on MAIT TCR activation; 
one mutation (Leu151Ala) resulted in enhanced autoreactiv-
ity in the absence of bacteria; and, most importantly, two 
mutants (Leu65 and Glu158) markedly reduced MAIT TCR 
activation (Fig. 7 A). The pattern of the effect of these mu-
tants was the same, regardless of which MAIT TCR was used 
chain mutants was otherwise very similar to that observed 
for the SKW3.TRBV20 cells, regardless of the source of the 
TCR  chain or the source of bacterial stimulation, again 
suggesting a passive role for the TCR  chain in direct 
Ag-specificity observed in our system. Specific responses were 
blocked by the anti-MR1 mAb 26.5 and were dose de-
pendent (unpublished data). Accordingly, MR1-restricted 
MAIT TCR–mediated activation is not modulated appre-
ciably by the TCR  chain, and is determined by the in-
variant  chain (Fig. 2 G).
A small energetic footprint on MR1
Having established that a small number of MAIT TCR resi-
dues were essential for MR1 recognition, we next explored 
whether the MAIT TCR–MR1 interaction was underpinned 
by a focused energetic “hot spot” on MR1. To establish this, 
we generated a homology model of human MR1 (see Mate-
rials and methods) and selected 14 residues, 6 on the 1-helix 
(Asp57, Arg61, Leu65, Met72, Val75, and Arg79) and 8 on the 
2-helix (Thr138, Gln141, Asn146, His148, Leu151, Asn155, 
Glu158, and Arg167). The selected residues were exposed to 
solvent, and thus represented potential MAIT TCR contact 
points. Moreover, the residues targeted for mutagenesis included 
charged, polar, and hydrophobic residues, and ran along the 
Figure 5. Activation of mutant SKW3.TRBV20 cell lines by different bacterial species. 11 mutant  chain (A) and 14 mutant  chain (B) SKW3.
TRBV20 cell lines were tested for activation by E. coli, S. epidermidis, K. pneumoniae, and P. aeruginosa. Shaded bars show the fold increase in CD69 sur-
face expression (fold increase in MFI) of mutant SKW3.TRBV20 cells co-incubated with C1R cells infected with bacteria at an MOI of 100 compared with 
SKW3.TRBV20 cells co-incubated with uninfected C1R cells (open bars). The experiments shown in A and B were also performed at an MOI of 1 and 10, 
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of the MAIT TCR–MR1 interaction is unclear, largely be-
cause the identity of the putative MR1-restricted ligand is 
unknown (Huang et al., 2008); indeed, it has not yet been 
definitively shown that MR1 presents self- or bacterially de-
rived Ags. Nevertheless, we used a combined structural and 
mutagenesis approach (a proven approach used to understand 
biased TCR usage in pMHC and CD1d-Ag recognition; 
Borg et al., 2005; Scott-Browne et al., 2007; Wun et al., 
2008) to provide the first insight into the specificity require-
ments that underscore MAIT cell activation by MR1. Ini-
tially, we determined the structure of the human MAIT 
TCR (V7.2J33-V2), which showed that the CDR loops 
formed an ordered Ag-binding interface, thereby suggesting 
that there is limited conformational plasticity in the MAIT 
TCR–MR1 interaction. Further, the MAIT TCR structure 
showed that the central binding pocket, lined by the CDR3 
and CDR3 loops, markedly contrasted to that of the human 
NKT TCR (Kjer-Nielsen et al., 2006), differences that pre-
sumably reflect that MAIT and NKT cells are activated by 
MR1 and CD1d, respectively.
Our MAIT TCR mutagenesis studies identified V resi-
dues Gly28 and Asn30 from CDR1, Tyr48 from CDR2, 
and Asp92, Asn94, and Tyr95 from CDR3 (J) as being 
in the activation assay. Strikingly, these two key positions 
map centrally to the MR1-Ag–binding cleft, directly oppo-
site each other (Fig. 7 B). Moreover, the “autoreactive” and 
less impacted positions are proximal to Glu158 on the 2-
helix. The effect of these key positions (Leu65 and Glu158) in-
dicates that there is a centrally located and extremely focused 
energetic hot spot on MR1 that underpins recognition by 
the MAIT TCR.
DISCUSSION
MAIT cells share many characteristics with NKT cells in that 
both cell types express invariant TCR- chains paired pref-
erentially with a restricted range of TCR- chains (Godfrey 
et al., 2010b). Minor differences exist in that the NKT recep-
tor  chain has little or no N-region variation at the V-J 
junction whereas MAIT  chains can tolerate some N-region 
variation at this junction (Tilloy et al., 1999; Bendelac et al., 
2007). Nonetheless, both types of T cell have appropriated 
their largely innate receptors from the pool of  TCRs that 
are considered part of the adaptive immune repertoire. Both 
T cells are activated by MHC-I–like Ag-presenting mole-
cules (CD1d and MR1 for NKT and MAIT cells, respec-
tively). In contrast to NKT recognition, the underlying basis 
Figure 6. The  chain residues crucial to MAIT TCR recognition are conserved in two other MAIT TCRs. The mutant  chain residues observed 
to diminish bacterial activation in SKW3.TRBV20 cell lines (Gly28Ala, Asn30Ala, Tyr48Ala, Asp92Ala, Asn94Ala, and Tyr95Ala, as well as control Ser27Ala 
and Ser93Ala mutations) were introduced into the MAIT.TRBV6-1 and MAIT.TRBV6-4 TCRs before transduction of MAIT TCR genes into SKW3 cells. SKW3.
TRBV6-1 and SKW3.TRBV6-4 cell lines transduced with mutants Ser27Ala, Gly28Ala, Asn30Ala, Tyr48Ala, or Tyr95Ala (A), or mutants Asp92Ala, Ser93Ala, 
or Asn94Ala (B) were then tested for activation by S. typhimurium, S. epidermidis, K. pneumoniae, and P. aeruginosa. Shaded bars show the fold increase 
in CD69 surface expression (fold increase in MFI) of mutant SKW3.TRBV6-1 or mutant SKW3.TRBV6-4 cells co-incubated with C1R cells infected with 
bacteria at an MOI of 100 compared with SKW3.TRBV6-1 or SKW3.TRBV6-4 cells co-incubated with uninfected C1R cells (open bars). These experiments 
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important or crucial for MAIT TCR activation, regardless of 
whether the MAIT TCR expressed V2 or V13. Notably, 
the importance of these residues in MR1-restricted activa-
tion explains the invariant selection of the V7.2-J33  chain 
segments that uniquely encode this cluster of residues. These 
residues are fully conserved in homologous V-J combina-
tions selected across humans, mice, sheep, and cattle (Tilloy 
et al., 1999; Goldfinch et al., 2010; Fig. S4). This pattern of 
germline V and J residues defining cognate activation 
therefore has a similar basis to the invariant selection of 
V24-J18 by NKT cells in their CD1d-restricted recognition 
of glycolipids (Gadola et al., 2006; Kjer-Nielsen et al., 2006).
The small energetic footprint of the MAIT TCR was 
mirrored by the small energetic footprint on MR1, where 
mutation of only two residues, Leu65 and Glu158, markedly 
reduced MAIT TCR activation, regardless of the V usage 
of the MAIT TCR. In addition, one mutation, Leu151Ala, 
promoted MAIT TCR–MR1 autoreactivity, and this posi-
tion was previously shown to determine human and mouse 
MAIT TCR–MR1 cross-species reactivity (Huang et al., 2009). 
These three positions clustered closely, and were centrally 
located within the Ag-binding cleft of MR1, tentatively sug-
gesting that the MAIT TCR docks centrally on MR1; it is 
also conceivable that these residues are involved in stabiliza-
tion of Ag binding to MR1. A central MAIT TCR–MR1 
docking mode would contrast with that of the NKT TCR–
CD1d-Ag interaction, in which the NKT TCR is perched 
above the F-pocket of CD1d, whereupon the CDR2 loop 
makes critical contacts with CD1d (Godfrey et al., 2010a).
In NKT cells, differential V usage is observed, with some 
regions of sequence conservation observed between the dif-
ferent V families. These conserved V residues were im-
portant not only for NKT cognate interaction but also for the 
cross-species reactivity between mouse and human CD1d 
(Wun et al., 2008). Although MAIT cells also preferentially 
select a few V families, there is limited sequence identity 
between the CDR1 and CDR2 regions of human V2 
and V13 (Tilloy et al., 1999), suggesting that the reported 
cross reactivity of human MAIT cells on mouse MR1 may be 
largely underpinned by the V-J chain residues interacting 
with the MR1 “hotspot.” Indeed, our functional data sug-
gests that differential V usage in MAIT cells cannot be as-
signed to single-residue contributions. Importantly, using a 
variety of bacteria as sources of MAIT TCR stimulation, we 
demonstrated that individual residues within the V chain 
did not play a controlling role in MAIT cell activation when 
analyzed by mutagenesis, which is perhaps consistent with 
the lack of  chain sequence conservation in humans. Figure 7. The effect of mutation of MR1 residues on MAIT TCR 
activation. (A) 13 mutant MR1, as well as wild-type MR1 (C1R.WT) and 
parental C1R, cell lines were either not infected (open bars) or infected 
(shaded bars) with S. typhimurium at a multiplicity of infection (MOI) of 1. 
After infection, Jurkat.TRBV 20, Jurkat.TRBV 6–1, or Jurkat.TRBV 6–4 cell 
lines were then added for 16 h before measurement of increase in CD69 
surface expression (MFI) by staining and flow cytometric analysis. This 
experiment was performed twice with similar results. Mutant Arg167Ala 
MR1 C1R cells activated Jurkat.MAIT cells similarly to wild-type MR1 C1R 
cells (not depicted). The experiment was also performed at an MOI of 10 
with similar results (not depicted). (B) The effects of the MR1 mutants 
were mapped onto the human MR1 homology model. Mutations that had 
no impact on MAIT TCR activation is shown in gray; impact on autoreac-
tivity is shown in orange; mutants that markedly reduced MAIT TCR acti-
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MAIT TCRs containing the CDR3 regions from either an abacavir- 
specific, TRBV20-positive T cell clone, ABC (Chessman et al., 2008); or 
from an Epstein–Barr-specific, TRBV6-1–positive T cell clone (SB27; Tynan 
et al., 2005b).
Activation studies with MAIT TCR–expressing T cell lines. Jurkat or 
SKW3 T hybridoma cells expressing human MAIT TCRs were incubated for 
16–20 h with APCs expressing human MR1 (or mutants thereof), in the 
absence or presence of S. typhimurium, P. aeruginosa, K. pneumoniae, E. coli, or 
S. epidermidis. Activation of MAIT TCR–expressing T cells was determined 
by flow cytometric analysis of up-regulation of cell surface CD69 expression. 
The 25 SKW3 cell lines expressing TRBV20 Ala substitutions were also incu-
bated with beads coated with anti-CD3 and anti-CD28 mAbs titrated to pro-
duce activation that just achieved plateau levels of stimulation of SKW3 cells 
expressing a wild-type MAIT TCR.
Generation of MAIT TCR mutants. MAIT TCR genes encoding single 
alanine-mutations were generated by the QuikChange Site-Directed Muta-
genesis method (Stratagene). All mutant genes were fully sequenced before 
subcloning into the 2A peptide-based pMIG vector and subsequent retro-
viral transfer into Jurkat and SKW3 cells. Residues to be mutated were se-
lected on the basis of the solved crystal structure of a MAIT TCR, and 
include the following CDR residues: CDR1: Ser27, Gly28, and Asn30; 
CDR2: Tyr48, Val50, Leu51, and Asp52; CDR3: Asp92, Ser93, Asn94, and 
Tyr95; CDR1: Phe28, Gln29, Thr31, Thr32, and Leu26 (Leu26 as a con-
trol); CDR2: Asn51, Glu52, Gly53, Ser54, and Lys55; CDR3: Arg97, 
Ser99, Gly100, and Phe102.
Protein expression and purification. The MAIT TRBV20 and TRBV6-1 
and TRBV6-4 TCRs were expressed, refolded, and purified using an engi-
neered disulfide linkage in the constant domains between the TRAC and 
TRBC, essentially as described previously (Clements et al., 2002). In brief, the 
 and  chain of the MAIT TCR were expressed separately as inclusion bod-
ies in BL21 E. coli strain. Inclusion bodies were resuspended in 8 M Urea, 
20 mM Tris-HCl, pH 8.0, 0.5 mM Na-EDTA, and 1 mM DTT. TCRs were 
refolded by flash dilution in a solution containing 5 M Urea, 100 mM Tris, 
pH 8.0, 2 mM Na-EDTA, 400 mM l-arginine-HCl, 0.5 mM oxidized gluta-
thione, 5 mM reduced glutathione, PMSF, and pepstatin A. The refolding 
solution was then dialyzed to eliminate the urea. The resulting refolded pro-
tein was then purified sequentially by DEAE anion exchange, gel filtration, 
and Mono-Q anion exchange chromatography.
Crystallization, structure determination, and refinement. The 
MAIT TCR V7.2J33-V2 (7–10 mg/ml in 10 mM Tris, pH 8.0, and 
150 mM NaCl) crystallized at 20°C in 25% PEG 1500, 0.1 M MIB buffer 
(sodium malonate/Imidazole/boric acid in molar rations of 2:3:3), pH 5.0, 
via the hanging drop vapor diffusion technique. Equal ratio of the protein 
to mother liquor resulted in plate-like crystals after 1–3 d. The crystals 
were flash frozen before data collection in mother liquor containing 20% 
glycerol. The crystals diffracted to 1.7 Å at the MX2 beamline at the Aus-
tralian Synchrotron facility in Melbourne, Australia (Table 1). The crystals 
belong to the space group P212121, with one molecule in the asymmetric 
unit. The crystal structure of the MAIT TCR was solved by molecular re-
placement method with the program Phaser from the CCP4 Suite (Col-
laborative Computational Project, Number 4, 1994), using ELS4 TCR 
(Protein Data Bank ID accession code 2NX5; Tynan et al., 2007) without 
the CDR loops and loops connecting the variable and constant domains as 
a model. ARP/wARP in the CCP4 suite (Collaborative Computational 
Project, Number 4, 1994) was used for automated model building, and 
Refmac was used for restrained refinement (Table 1). The quality of struc-
ture was confirmed at the Research Collaboratory for Structural Bioinfor-
matics Protein Data Bank Data Validation and Deposition Services website 
(http://www.rcsb.org/pdb/home/home.do; Protein Data Bank accesion 
code 4DZB). All molecular graphics representations were created using 
PyMOL (DeLano, 2002).
However, replacement of whole MAIT CDR3 loops with 
those from non–MAIT TCRs abolishes T cell activation in-
dicating a more complex role for CDR3 residues in MAIT 
specificity. It is possible that the conformation of the CDR3 
loop can impact on the conformation of the CDR3 loop, 
thereby impacting MR1 recognition in a manner similar to 
how V-based changes impact the NKT TCR  chain con-
formation and resultant CD1d-Ag recognition (Kjer-Nielsen 
et al., 2006; Pellicci et al., 2009), or in a manner analogous to 
that recently observed in MHC-restricted immunity (Stadinski 
et al., 2011). It is also possible that the selective V usage by 
MAIT cells is shaped by a putative positive selecting endoge-
nous ligand, as suggested for NKT cells (Wei et al., 2006), 
and/or avoidance of self-MR1 reactivity with endogenous 
MR1-bound ligands.
In MHC-restricted immunity, the TCR can ligate the 
pMHC landscape through a range of docking modes to me-
diate viral immunity, alloreactivity, and autoimmunity (Burrows 
et al., 2010). This variability is attributable to the highly poly-
morphic nature of the MHC molecules, the variable peptide 
cargo, and the diversity of TCR V and V usage. More-
over, MHC-restricted TCRs are inherently cross-reactive 
(Archbold et al., 2008), and this cross-reactivity is often man-
ifested in conformational plasticity of the CDR loops (or the 
pMHC itself; Tynan et al., 2007; Archbold et al., 2009) upon 
TCR-pMHC ligation. In contrast, our data suggest that the 
MAIT TCR might be relatively rigid, which is characteristic 
of innate receptors styled to recognize monomorphic or only 
modestly variable Ags. Moreover, the crucial role for the same 
TCR V-J residues in recognizing different species of Gram-
negative and -positive bacteria suggests a highly conserved 
MR1 docking mode that underpins MAIT cell activation by 
diverse microbes. Collectively, our studies have provided the 
first fundamental insight into the MAIT TCR–MR1 inter-
action and the basis for invariant TCR chain selection.
MATERIALS AND METHODS
Generation of MR1-expressing APCs. Full-length cDNA genes encod-
ing either human or murine MR1 were cloned into a modified version of 
p-MSCV-IRES-eGFP (pMIG; D. Vignali, St. Jude Children’s Research Hospi-
tal, Memphis, TN; Liu et al., 1997; Pear et al., 1998). 293T packaging cells 
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